Dr. Cecelia Yates to Receive the Emerging Innovator Award
McGowan Institute for Regenerative Medicine affiliated faculty member Cecelia Yates, PhD is the recipient of the 2020 Emerging Innovator...
medicine focused on developing and delivering
therapies that reestablish tissue and organ function
impaired by disease, trauma or congenital abnormalities.
GENE THERAPY
Phase I Clinical Trial Next Step
TRANSPLANTATION
Mimicking Cancer to Avoid Transplant Rejection
Introduction to The McGowan Institute
To provide a national center of expertise in regenerative medicine. Watch Our Video
Technology Spotlight
McGowan’s Quality Management Specialists Assist Pitt’s Center for Vaccine Research. Read More
Featured News
Dr. William Federspiel to Receive the 2020 Marlin Mickle Outstanding Innovator Award
William Federspiel, PhD, Director of the Medical Devices Laboratory at the McGowan Institute for Regenerative Medicine, is the recipient...
Stem Cells Derived from Fat Show Promise as a Treatment for Mass Radiation Exposure
Nuclear power offers an efficient, reliable way to provide energy to large populations - as long as all goes...
Pre-Pandemic Hospital Surge Capacity ‘Time Capsule’
A University of Pittsburgh School of Medicine-led survey of dozens of surge capacity managers at hospitals nationwide captures the...
Video: Hope vs. Hype of Stem Cell Therapy
